ClinicalTrials.gg
Status unknownNCT05713084Updated Feb 6, 2023

Condylar Position Changes and TMJ Functions After BSSO Mandibular Setback, Low Medial Cut.

An interventional study of mandibular setback using BSSRO in Maxillofacial Abnormalities, Mandible Prognathism and Skeletal Malocclusion, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study hypotheses that using low medial cut osteotomy BSSO in mandibular setback can be an efficient and effective method to limit the bony segment interferences , decreasing muscles stripping during osteotomy ,decrease condylar torque and so securing preoperative condylar position during BSSO in comparison with using high medial cut BSSO.

Read the detailed description

Research question:

Description of research question:

P: Population: Patients with facial skeletal deformity and need for mandibular setback using bilateral sagittal split osteotomy (BSSRO) alone or combined with lefort osteotomy.

I: Intervention: Patients with facial skeletal deformity and need and for mandibular setback using low medial cut osteotomy as modification of bilateral sagittal split ramus osteotomy (BSSRO).

C: Comparator: Patients with facial skeletal deformity and need and for mandibular setback using traditional high medial cut osteotomy bilateral sagittal split ramus osteotomy (BSSRO).

O: Outcome: Comparing the post-operative condylar positions changes and TMJ functions of two osteotomies.

Research question:

Is using low medial cut osteotomy modification in BSSRO in mandibular setback will provide more control over proximal segment position than traditional high medial cut through:

  1. limit the segments interference and so maximizes the passive bony contact across the osteotomy site after surgically repositioning the distal segment
  2. Passively positioned the proximal segment without displacement of the condyle from its normal position.
02

Conditions studied

  • Maxillofacial Abnormalities
  • Mandible Prognathism
  • Skeletal Malocclusion

Keywords

  • mandibular setback
  • low medial cut
  • condylar position
03

In context

Maxillofacial Abnormalities

21 studies on the registry are indexed under Maxillofacial Abnormalities; 2 are open to participants now.

This study's planned enrollment of 24 is below the median of 49 across 10 interventional studies indexed under Maxillofacial Abnormalities.

Browse Maxillofacial Abnormalities studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of the patient between (18-60) years
  • Patients in need of mandibular setback using bilateral sagittal split osteotomy.
  • All patients are free from any systemic disease that may affect normal bone healing.
  • Patient with facial deformity will be treated with mandibular setback either mono or bimaxilary surgeries
  • Patient with facial deformity will be treated with mandibular setback either surgery first approach or orthofirst approach.
  • Sufficient dentition to reproduce the occlusal relationships
  • Patient's consent to participate

Exclusion criteria

Exclusion criteria:

  • Patients with any systemic disease that may affect normal healing
  • Intra-bony lesions or infections that may interfere with surgery.
  • Previous orthognathic surgeries.
  • Patients with all types of facial clefts
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    mandibular setback using low medial cut ostetomy

    mandibular setback using low medial cut ostetomy by keeping the cut ''low'' or close to the mandibular occlusal plane and ''short'' or terminating anterior to the lingula.

    Other: mandibular setback using BSSRO

  • Active comparator
    mandibular setback using high medial cut ostetomy

    mandibular setback by placement of the medial ramus osteotomy cut 'high', just a few millimeters above the lingula, superior and lateral to the entrance point of the inferior alveolar nerve (IAN) into the mandibular foramen ,

    Other: mandibular setback using BSSRO

Interventions

  • Othermandibular setback using BSSRO

    mandibular setback using BSSRO

06

What researchers measure

Primary outcomes

  1. 3D mandibular condylar position changes

    assessment of condylar position changes in millimetre using C.T.(axial ,coronal and sagital cut. ). 1. Axial condylar head long-axis angle (AHA): angle between the sagittal plane and the axial condylar head axis line 2. Axial condylar head position (AHP): perpendicular distance between the sagittal plane and the most medial point of the condylar head 3. Frontal condylar head long-axis angle (FHA): angle between the axial plane and the frontal condylar head long-axis line 4. Frontal condylar head position (FHP): perpendicular distance between the axial plane and most superior point of the condylar head 5. Sagittal condylar head long-axis angle (SHA): angle between the coronal plane and the sagittal condylar head long-axis line 6. Sagital condylar head position (SHP): perpendicular distance between the coronal plane and the most superior point of the condylar head

    Time frame: Preoperative- 1-month postoperative - 6 months post operative

Secondary outcomes

  1. Assessment of changes in articular disc position

    In order to trace the position of the TMJ disc, a line was drawn from the uppermost point of the articular fossa (UAF, marked as 10) to the lowermost point of the articular tubercle (LAT, marked as 0). This line was continued anteriorly and inferiorly. If the anterior border of the disc was anterior to this line, it was considered negative. These two points were chosen because they did not change with remodelling . Perpendicular lines to this line were drawn in the anterior and posterior borders of the disc. Finally, disc position was determined by averaging anterior (point A) and posterior (point P) disc limits.

    Time frame: Preoperative , 6month postoperative

Other outcomes

  1. Clinical assessment of maximum incisal opening (MIO)

    assessment of changes(in millimetre) in Maximum incisal opening (MIO)

    Time frame: Preoperative - 1 months postoperative - 6 months postoperative

  2. pain on TMJ

    assessment of changes in severity of pain over TMJ using (pain scale from 0 to 10)

    Time frame: Preoperative - 1 months postoperative - 6 months postoperative

  3. sounds on TMJ

    assessment of resulted sounds during TMJ function (present or not present)

    Time frame: Preoperative - 1 months postoperative - 6 months postoperative

07

Study locations

1 site
  • Faculty of Dentistry Cairo University
    Cairo, 11553, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2022 (actual). Primary completion is estimated for Apr 2023, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2023
First posted
Feb 6, 2023
StartActual
Sep 28, 2022
Primary completionEst.
Apr 2023
CompletionEst.
Sep 2023
Last update
Feb 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05713084
Lead sponsor
Cairo University
Responsible party
Mahmoud Mohammed Mahmoud Hussein Alaswad (Principal Investigator, Cairo University) — Principal investigator
First posted
Feb 6, 2023
Start date
Sep 28, 2022
Primary completion
Apr 2023 (estimated)
Completion
Sep 2023 (estimated)
Last update
Feb 6, 2023

Study contacts

Fahmy Mobarak, professor
study director · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion